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LONG-DISTANCE PHYSICAL CONNECTIONS BETWEEN
CHONDROCYTES; CELL-TO-CELL COMMUNICATION WITHIN
HYALINE CARTILAGE
M. Mayán 1, R. Gago 1, P. Carpintero 1, P. Filgueira-Fernández 1,
N. Goyanes 1, V. Valiunas 2, P. Brink 2, F.J. Blanco 1. 1Osteoarticular and
Aging Res. Lab. INIBIC-CHUAC, A Coruña, Spain; 2Dept. of Physiology
and Biophysics, State University of New York, Stony Brook, NY, USA
Purpose: Even chondrocytes are metabolically active cells, responsible of
the maintenance of the hyaline cartilage during the whole adult life, it is
highly accepted in the ﬁeld that chondrocytes in cartilage do not connect
each other, as they are isolated inside their lacunae separated from each
other by a distance between 5 to 60mm. In the same lacuna can co-exit
several chondocytes interacting between them. However, how the chon-
drocytes from different lacuna interact between each other and timely
respond to physical or chemicals stimuli, are largely unknown. Thus far,
the unique communication between chondrocytes in the superﬁcial layer
with chondrocytes in themiddle and deeper layers it is accepted that only
occurs through diffusion. Nevertheless, the intercellular communication
confers to a tissue the ability to responduniformly to localized stimuli. The
purpose of this study was to investigate how chondrocytes communicate
each other within the matrix and ﬁnd for some alteration that could
explain the degeneration of the matrix that occurs in patients with OA.
Methods: In situ cartilage from human and Sus scrofa were ﬁxed and
frozen immediately using Tissue-Tek O.C.T. and isopentanol in liquid
nitrogen. Samples were ﬁxed with acetone for confocal optical
microscopy assays. Samples were embedded in cacodylate buffer before
dehydratation for Scanning Electron Microscope (SEM). Gold was use
for coating. Frozen samples were also used for immunoﬂuorescence and
immunohistochemistry assays. For total RNA isolation, the proteins and
DNA were removed from cell extracts using TRIZOL Reagent (Invi-
trogene) before using the RNeasy Kit (Qiagen) which includes DNase
treatment (RNAse-Free DNAse Set). Quantiﬁcations were done using
SYBr green real-time PCR. Virgin Valiunas performed dual voltage-
clamp method and whole-cell/perforated patch using chondrocytes
from healthy donors and patients with OA.
Results: By using confocal optical microscopy and Scanning Electron
Microscopy (SEM), we have found that chondrocytes are physical con-
nected between each other across the extracellular matrix through
large cytoplasmic projections. The projections are between 5 to 150 mm
in length in human healthy cartilage and young cartilage from Sus
scrofa. However condrocytes projections found in OA cartilage are
between 10 to 200 mm in length. High levels of expression for the gap
junction protein connexin 43 have been detected by RT-PCR and
immunohistochemical experiments. We have also found expression of
Cx32 and Cx45, however electrophysiology experiments demonstrated
that healthy and OA chondrocytes show voltage-dependent behaviour
for channels mainly formed by Cx43. We have performed patch clamp
experiments to study the interchange of Lucifer Yellow and small
molecules of RNA. Our results demonstrated that healthy and OA
chondrocytes are able to interchange Lucifer Yellow and small mole-
cules of RNA through Cx43 channels. In fact, our preliminary results
showed that inhibition of channels affect the synthesis of collagen type
II, MMP3 andMMP9 suggesting that the activity of channels are actively
involved with the maintenance of the cartilage matrix.
Conclusions:Wehavefoundcell/cellphysicalconnectionsthroughall layers
of cartilage between chondrocytes located at different distance within
cartilage. Intercellular communication occurs through channels voltage-
dependent formedby Cx43. Cytoplasmic projections fromOAchondrocytes
are longer than from healthy chondrocytes, therefore the channel activity
can be affected by the electrical depolarization of the membrane in OA
chondrocytes. We have found that chondrocytes interchange small RNAs
and inhibition of channels affect the expression of matrix-related genes.
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SYNERGISTIC INDUCTION OF ELF3. IN VITRO EFFECT OF LEPTIN AND
IL-1 IN HUMAN CHONDROCYTES
J. Conde 1, M. Scotece 1, M. Otero 2, R. Gomez 1, J.J. Gomez-Reino 1,
M.B. Goldring 2, O. Gualillo 1. 1 SERGAS, Santiago Univ. Clinical Hosp.
NEIRID LAB, Santiago de Compostela, Spain; 2Hosp. for Special Surgery,
New York, NY, USA
Purpose: To investigate whether leptin, alone or in combination with
IL-1b, is able to induce the expression of the novel Ets transcriptionfactor ELF3, and to dissect the role of leptin receptor signalling pathway
analyzing the role of several kinases and NF-kB. For completeness,
pharmacological modulation by dexamethasone was also investigated.
Methods: The human juvenile costal chondrocyte cell line T/C-28a2
was analyzed for the expression of ELF3 mRNA in resting condition and
upon stimulation with leptin alone or in combination with IL-1b by
using quantitative RT-PCR. Pharmacological modulation of ELF3 mRNA
expression by dexamethasone and the effect of kinases inhibitors such
as tyrphostin, wortmannin, LY294002 and SB203580 were also
analyzed by qRT-PCR. Ablation of leptin receptor was obtained by using
siRNA. The wild type ELF3 promoter and the ELF3 promoter mutated in
the NF-kB site were cloned into a luciferase reporter vector and
analyzed in transient transfections.
Results: When T/C-28a2 cells were treated with leptin in combination
with IL-1b a synergistic induction of ELF3 mRNA expression was
observed in comparison to IL-1b treatment alone. Leptin synergism is
completely blunted by dexamethasone, by leptin receptor ablation and
by selective inhibitors of JAK2 kinase, PI3 kinase and p38 kinase. Leptin
synergism is dependent on the integrity of NF-kB binding site in the
ELF3 promoter.
Conclusions: Leptin synergizes with IL-1b to induce ELF3 in human
chondrocytes. The synergism is criticallymodulated by dexamethasone,
by leptin receptor signalling cascade, and is dependent on NF-kB.
Overall, this work highlights a novel and fundamental role for leptin in
promoting and perpetuating inﬂammatory response in chondrocytes
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NOTCH/RBPJ/HES1 SIGNAL IN CHONDROCYTES MODULATES
OSTEOARTHRITIS DEVELOPMENT
S. Sugita 1, Y. Hosaka 1, T. Hikata 2, H. Akiyama 3, F. Long 4, U-i. Chung 1,
T. Saito 1, H. Kawaguchi 1. 1 The Univ. of Tokyo, Tokyo, Japan; 2Keio Univ.,
Tokyo, Japan; 3Kyoto Univ., Kyoto, Japan; 4Washington Univ. in St. Louis,
St. Louis, MO, USA
Purpose: The Notch signaling pathway, a potent modulator of cell
differentiation in many organs, is regulated by several molecules: the
Notch receptors, the transcriptional effector Rbpj, and the target tran-
scription factor Hes/Hey family members. Here we have examined the
roles of these molecules in chondrocytes during the endochondral
ossiﬁcation process which is essential for skeletal growth and osteo-
arthritis (OA) development.
Methods: In vitro expression patterns were examined by real-time RT-
PCR and Western blotting in cultures of mouse chondrogenic ATDC5
cells with the differentiation medium (insulin, transferrin, and sodium
selenite) and primary chondrocytes isolated from the ribs of mouse
embryos. In vivo expression patterns were examined by immunohis-
tochemistry of the limb cartilage of mouse embryos and knee OA joint
cartilage of the mouse experimental model. Tissue-speciﬁc knockout
mice were generated by mating Sox9-Cre knock-in mice or Tamoxifen
(TM)-inducible Col2a1-Cre transgenic mice (Col2a1-CreTM), with mice
homozygous for a ﬂoxed Rbpj allele (Rbpjﬂ/ﬂ) or those homozygous for
a ﬂoxed Hes1 allele (Hes1ﬂ/ﬂ). For analyses of OA, TM was injected into
7-week-old Col2a1-CreTM;Rbpjﬂ/ﬂ mice or Col2a1-CreTM;Hes1ﬂ/ﬂ
mice, and the OAmodel was created surgically by inducing instability in
the knee joints one week after this injection. OA severity was quantiﬁed
by the OARSI histopathology grade 8 weeks after surgery. Functional
roles of the Notch-related molecules were examined using ATDC5 cells
transfected with the expression vectors, and/or the siRNA vectors.
Transcriptional regulation was examined by luciferase assay using
ATDC5 cells transfected with the reporter construct containing
a promoter fragment of the marker genes.
Results: In cultures of ATDC5 cells and primary chondrocytes, Notch1, 2,
Rbpj, and Hes1 were strongly expressed in their terminal differentiation
stages during Mmp13 expression, while Notch3, 4 and other Hes/Hey
members were little expressed throughout the differentiation stages. In
the mouse limb cartilage and in the knee OA joint cartilage, the intra-
cellular domains (ICDs) of Notch1, 2 were localized in the nucleus of
highly differentiated chondrocytes in the hypertrophic zone and in the
degraded cartilage, respectively, while they remained in the cytoplasm
of less differentiated chondrocytes of the proliferative zone and unde-
graded cartilage. Rbpj and Hes1 were also co-expressed in the nucleus
of highly differentiated chondrocytes, while other Notch ICDs and Hes/
Hey family members were not detected in either cartilage. Both Sox9-
Cre;Rbpjﬂ/ﬂ mice and Sox9-Cre;Hes1ﬂ/ﬂ mice died shortly in the
perinatal period; however, Sox9-Cre;Rbpjﬂ/ﬂ embryos exhibited
Table 1
Cartilage loss (mm) in cases with knee replacement (KR) and matched controls
KLG2 KLG3 KLG4
KR
Cases
Matched
Controls
KR
Cases
Matched
Controls
KR
Cases
Matched
Controls
cMFTC Median -0.15 +0.03 -0.17 -0.12 -0.08 -0.09
Mean -0.57 0.00 -0.26 -0.12 -0.12 -0.09
MFTC Median -0.07 +0.01 -0.13 -0.08 -0.07 -0.05
Mean -0.26 +0.03 -0.18 -0.09 -0.07 -0.05
OV1 Median -0.27 -0.14 -0.29 -0.22 -0.24 -0.20
Mean -0.59 -0.15 -0.37 -0.24 -0.28 -0.25
KR¼ knee replacement; KLG¼ Kellgren Lawrence grade; (c)MFTC¼ (central) medial
femorotibial compartment; OV ¼ ordered value
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due to decrease of Mmp13 expression, while Sox9-Cre;Hes1ﬂ/ﬂ
embryos exhibited normal sketetal growth. When we created the
experimental OA model in TM-inducible knockout mice, the knee OA
development was suppressed in both Col2a1-CreTM;Rbpjﬂ/ﬂ mice and
Sox9-Cre;Hes1ﬂ/ﬂ mice as compared to the respective control litter-
mates, with prevention of the terminal stage of endochondral ossiﬁ-
cation. ATDC5 cells overexpressing Notch1-ICD showed enhanced
expression of Mmp13 and Hes1 in one-week pellet culture. Further-
more, the enhancement of Mmp13 expressionwas partially canceled by
inhibition of Hes1 expression though the speciﬁc siRNA transfection.
Luciferase analyses revealed that the Hes1 transfection enhanced the
MMP13 promoter activity most potently among the Hes/Hey members.
Conclusion: The Notch/Rbpj/Hes1 signal in chondrocytesmodulates OA
development by induction of MMP13, indicating it as a possible ther-
apeutic target of OA.
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CARTILAGE LOSS, MEASURED WITH MRI, PREDICTS KNEE
REPLACEMENT - DATA FROM THE OSTEOARTHRITIS INITIATIVE
F. Eckstein 1,2, C.K. Kwoh 3, R. Boudreau 4, Z. Wang 3, M.J. Hannon 3,
S. Cotofana 1,2, M. Hudelmaier 1,2, W. Wirth 1,2, A. Guermazi 5,6,
M. Nevitt 7, M.R. John8, D.J. Hunter 9. for the OAI investigators1Paracelsus
Med. Univ., Salzburg, Austria; 2Chondrometrics GmbH, Ainring, Germany;
3Univ. of Pittsburgh and Pittsburgh VAHS, Pittsburgh, PA, USA; 4Univ. of
Pittsburgh, Pittsburgh, PA, USA; 5Boston Univ., Boston, MA, USA; 6Boston
Imaging Core Lab (BICL), Boston, MA, USA; 7OAI Coordinating Ctr., UCSF,
San Francisco, CA, USA; 8Novartis Pharma AG, Basel, Switzerland; 9Univ.
Sydney, Sydney, Australia
Purpose: Knee OA has been shown to reduce quality of life and increase
health care utilization. In the absence of disease modifying drugs
(DMOADs), knee replacements (KR) are projected to increase to over 3
million annually in the US by 2030. Imaging biomarkers capable of
predicting relevant clinical endpoints, such as KR, may be valuable tools
for testing the efﬁcacy of DMOADs in clinical trials. The purpose of this
study was thus to examine whether MRI-based longitudinal measures
of cartilage loss predict knee replacement, whether prediction differs by
radiographic disease stage, and whether ordered values (OVs) of
subregional cartilage change provide a better prediction than region-
speciﬁc measures.
Methods: Knees from Osteoarthritis Initiative (OAI) participants who
received a KR between 12 and 48 month follow-up (conﬁrmed by
radiography and/or review of hospital records) were studied. One
matched control knee was selected for each KR case from OAI partici-
pants with the same Kellgren Lawrence (KL) grade at baseline (central
X-ray readings strata 0-1, 2, 3, 4), with the same sex and age (within 5 y),
who did not receive a KR during this period. Quantitative measures of
cartilage were obtained from a sagittal 3T DESSwe MRI sequence. The
time point prior to the occurrence of a KR (T0) and that 12 months
earlier (T-1) were analyzed. Segmentation of weight-bearing femoroti-
bial cartilage was performed by 12 readers (Chondrometrics GmbH,
Ainring, Germany) with blinding to acquisition order. Cartilage thick-
ness (ThCtAB) was determined in 16 subregions. The central medial
compartment (cMFTC) was selected as primary endpoint, the total
medial compartment (MFTC) as secondary endpoint, and OVs as
exploratory endpoints. P-values for differences in cartilage loss between
case/control pairs were computed using the Wilcoxon signed rank test,
and AUCs (with adjustment for matching variables) using ROC analysis.
Results: 191 knees of 165 OAI participants received a KR, of whom 109
had central X-ray readings at the time of analysis, MRI data at both T0
and T-1, and a matched control (46 men, 63 women, age 63.88.9, BMI
29.95.0). Longitudinal cartilage loss (Table 1) in cMFTC (p¼0.007,
AUC¼0.59) and MFTC (p¼0.014, AUC¼0.58), over a 12 month period
prior to KR, discriminated signiﬁcantly between KR cases and controls.
Discrimination for cMFTC was greater in KLG2 (n¼20; p¼0.009;
AUC¼0.67) than in KLG3 (n¼39; p¼0.16; AUC¼0.55) or KLG4 (n¼45;
p¼0.65; AUC¼0.54).
OV1 (the subregion with maximal loss in each knee independent of
location) tended to discriminate better between KRs and controls overall
(p¼0.0006, AUC¼0.63) and in KLG2 (p¼0.004, AUC¼0.79) and KLG3
knees (p¼0.02; AUC¼0.62) compared to cMFTC, but the differences in
AUCs did not reach statistical signiﬁcance. OVs 1 through 8 differed
signiﬁcantly between KRs and controls, whereas only 3 (of the 16)
subregions showed signiﬁcant differences between KR and control knees.Conclusions: Quantitative MRI measures of cartilage thickness loss
predict KR, particularly at the earlier stages of radiographic knee OA.
Point estimates for AUCs suggest that OV1 performs better in predicting
KRs than location speciﬁc measures, but with current sample size the
differences did not reach statistical signiﬁcance. The use of OV1
circumvents the need to choose a speciﬁc region a priori as a primary
endpoint and/or to adjust for comparing multiple regions of interest.
Quantitative measures of cartilage loss may be used in clinical trials to
demonstrate efﬁcacy of DMOADs. Also, the current ﬁndings support the
concept that treatments that slowcartilage lossmaydelayor prevent KR.
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TOTAL HIP REPLACEMENT BUT NOT CLINICAL OSTEOARTHRITIS CAN
BE PREDICTED BY SHAPE VARIATIONS OF THE HIP: A PROSPECTIVE
COHORT STUDY (CHECK)
R. Agricola 1, S. Bierma-Zeinstra 1, J. Verhaar 1, H. Weinans 1,2,
J. Waarsing 1. 1 Erasmus Med. Ctr., Rotterdam, Netherlands; 2Delft Univ.
of Technology, Delft, Netherlands
Purpose: Osteoarthritis (OA) of the hip can be deﬁned by both radio-
graphic and clinical criteria. Previously, it has been shown that radio-
graphic criteria associate to the shape of the hip. However, it is
unknown whether shape variations of the hip also associate with hip
OA deﬁned by clinical criteria. We aimed to determine the contribution
of hip shape in the prediction of both end-stage OA (THR) and general
clinical OA (ACR criteria) in a prospective cohort.
Methods: Individuals were extracted from the CHECK (cohort hip and
cohort knee) study. CHECK is a prospective cohort study of individuals
with assumed early symptomatic OA of knee or hip. Of the 1002 indi-
viduals, a random subset of 865 had standardized anteroposterior
radiographs (AP) taken at both baseline and 5 years follow-up. AP-pelvic
radiographs of sufﬁcient qualitywere obtained in 723 subjects at baseline
and in 770 subjects at 5 years follow-up. The shape of the proximal femur
and acetabulum on the AP radiographs was assessed using statistical
shapemodelling (SSM). The shapewasdeﬁnedbya set of landmarkpoints
that are positioned along the contour of the bone in the image (Figure 1).
An SSM describes all variation in shape of the complete cohort by several
independent shape aspects calledmodes. Hips that had received TotalHip
Replacement (THR) within 5 years were classiﬁed as end-stage OA and
hips fulﬁlling the ACR criteria after 5 years based on history, physical
examination, and laboratory ﬁndings were classiﬁed as clinical OA. The
association between each mode and both outcome measures was calcu-
lated by Generalized Estimating Equations (GEE), corrected for sex and
age. To correct for multiple testing, a p-value of 0.0017 was used to
determine statistical signiﬁcance (0.05 was divided by the 30 modes
tested). The predictive value of the GEE model including all univariate
signiﬁcantmodeswas then tested by the area under the ROC curve (AUC).
Results: For this study, 682 females (meanage 55.8) and183males (mean
age 56.4) were included. At baseline, 75% of the hips had no signs of OA
(K&L¼0) whereas 25% had doubtful OA (K&L¼1).When corrected for age
and sex, nine modes at baseline associated signiﬁcantly with the devel-
opment of end-stage OA within 5 years (Table 1). For example, mode 12
which resulted in the largest odds ratio of 2.34, illustrates superior joint
space narrowing and overcoverage of the acetabulum. When combining
thesemodes, only the four modes which associatedmost with end-stage
OA (mode 4, 11, 12, 15) were selected for calculating the AUC, to prevent
overﬁtting of the model. The predictive value of those four modes in the
GEE model resulted in an AUC of 0.81. At baseline, no modes associated
signiﬁcantly with the presence of clinical OA at 5 years.
